Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Philip Morris
PM
$299B
| $809M | 0.4% |
11,544,497
-17,001
| -0.1% | -$1.24M |
|
52
Salesforce
CRM
$148B
| $760M | 0.37% |
4,056,099
+102,818
| +3% | +$17.3M |
|
53
CVS Health
CVS
$134B
| $738M | 0.36% |
11,360,708
-5,615,306
| -33% | -$354M |
|
54
Nike
NKE
$62.7B
| $732M | 0.36% |
7,463,095
+1,709,288
| +30% | +$158M |
|
55
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $710M | 0.35% |
18,314,520
-2,154,636
| -11% | -$78.7M |
|
56
Thermo Fisher Scientific
TMO
$214B
| $676M | 0.33% |
1,866,527
-10,874
| -0.6% | -$3.64M |
|
57
Amgen
AMGN
$209B
| $661M | 0.32% |
2,800,835
-53,551
| -2% | -$12.2M |
|
|
58
Bristol-Myers Squibb
BMY
$132B
| $656M | 0.32% |
11,162,789
-8,458,990
| -43% | -$506M |
|
59
Eli Lilly
LLY
$1.03T
| $639M | 0.31% |
3,889,048
+89,685
| +2% | +$13.8M |
|
60
Costco
COST
$423B
| $633M | 0.31% |
2,086,280
+11,195
| +0.5% | +$3.41M |
|
61
iShares Core US Aggregate Bond ETF
AGG
$138B
| $619M | 0.3% |
5,234,601
+1,615,534
| +45% | +$189M |
|
62
Kimberly-Clark
KMB
$36.6B
| $618M | 0.3% |
4,372,857
+1,406,339
| +47% | +$194M |
|
63
Becton Dickinson
BDX
$45.6B
| $609M | 0.3% |
2,610,323
+103,736
| +4% | +$25M |
|
64
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| $606M | 0.3% |
21,556,206
+2,587,472
| +14% | +$72M |
|
65
Medtronic
MDT
$110B
| $605M | 0.3% |
6,601,700
-218,291
| -3% | -$20.9M |
|
66
Prologis
PLD
$136B
| $603M | 0.3% |
6,456,687
-3,561,710
| -36% | -$318M |
|
|
67
US Bancorp
USB
$98B
| $600M | 0.29% |
16,297,120
+9,723,270
| +148% | +$346M |
|
68
Crown Castle
CCI
$33.4B
| $595M | 0.29% |
3,557,285
+1,701,957
| +92% | +$274M |
|
69
Schwab International Equity ETF
SCHF
$67B
| $594M | 0.29% |
39,946,944
+264,430
| +0.7% | +$3.72M |
|
70
Dominion Energy
D
$61.3B
| $586M | 0.29% |
7,216,262
+3,565,738
| +98% | +$286M |
|
71
Broadcom
AVGO
$1.85T
| $575M | 0.28% |
18,214,770
+663,800
| +4% | +$18.6M |
|
72
Truist Financial
TFC
$63.5B
| $571M | 0.28% |
15,209,656
+15,892
| +0.1% | +$572K |
|
73
Citigroup
C
$222B
| $556M | 0.27% |
10,887,349
-389,557
| -3% | -$18.5M |
|
74
Starbucks
SBUX
$121B
| $552M | 0.27% |
7,507,504
-116,128
| -2% | -$8.73M |
|
75
Union Pacific
UNP
$172B
| $534M | 0.26% |
3,156,202
-33,888
| -1% | -$5.43M |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.